Results 41 to 50 of about 6,122,672 (198)

Giant basal cell carcinoma of the scrotum: A case report and review of the literature

open access: yesJEADV Clinical Practice, 2022
Basal cell carcinoma (BCC) is the most common skin cancer. However, BCC on the scrotum is very rare, with an incidence of 0.03%. Giant BCC, in which the tumour is larger than 5 cm, has also been reported as a rare variant.
Hiroki Ogawa   +5 more
doaj   +1 more source

Giant basal cell carcinoma

open access: yesPlastic & Reconstructive Surgery, 2012
The basal cell carcinoma is the most common skin cancer but the giant vegetating basal cell carcinoma reaches less than 0.5 % of all basal cell carcinoma types. The Giant BCC, defined as a lesion with more than 5 cm at its largest diameter, is a rare form of BCC and commonly occurs on the trunk.
Nasser, Nilton   +3 more
openaire   +6 more sources

Clinical periodontal diagnosis

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi   +5 more
wiley   +1 more source

Melanoma metastasizing into a basal cell carcinoma

open access: yes, 2022
Background: Basal cell carcinomas (BCC), being the most common diagnosed skin cancer in Australia, are frequently encountered in routine practice. Rarely, these tumours occur concurrently with melanomas, given the common risk factor of UV radiation ...
Hughes, L, Gounden, S
core   +1 more source

Successful treatment of giant basal cell carcinoma with topical imiquimod 5% cream with long term follow-up

open access: yesIndian Journal of Dermatology, 2014
The use of the topical Imiquimod 5% cream offers a noninvasive, nonsurgical, and an effective option for the treatment of primary small (5 cm) BCC with topical Imiquimod 5% cream are rare. We present our experience in the treatment of two giant tumors (6
M Chun-Guang   +5 more
doaj   +1 more source

Clinical features, pathology, and surgical management of periocular giant basal cell carcinoma

open access: yesJournal of Mind and Medical Sciences, 2020
Objectives. Basal cell carcinomas (BCCs) are malignant tumors which rarely metastasize, are slow-growing, and extensively locally destructive. BCCs more than 5 cm in diameter are defined as giant.
Oxana Madalina Grosu   +3 more
doaj   +1 more source

Sclerodermiform basal cell carcinoma in an elderly woman

open access: yes, 2023
The most commonly detected non-melacytic skin tumor in humans is "basal cell carcinoma". There are many clinical varieties of this tumor, some of which are quite rare.
Ekaterina V. Zadionchenko   +1 more
core   +1 more source

The Natural Product Corramycin Acts as a DNA Gyrase Poison and Overcomes Fluoroquinolone Resistance in Mycobacterium tuberculosis

open access: yesAdvanced Science, EarlyView.
Corramycin, a myxobacterial natural product antibiotic, exhibits potent bactericidal activity against multidrug‐resistant Mycobacterium tuberculosis. The compound hijacks bacterial transporters such as BacA and OppABCD to enter the cell and inhibits DNA synthesis through a previously unrecognized mode of DNA gyrase poisoning, locking the enzyme in an ...
Franziska Fries   +25 more
wiley   +1 more source

Risk of basal cell carcinoma after Hodgkin's disease [PDF]

open access: yes, 2000
Background: Basal cell cancer is a common skin cancer, yet studies of second tumors after Hodgkin's disease tend to exclude basal cell cancers as second malignant tumors from analysis.
Hölzel, Dieter   +5 more
core   +1 more source

Structural Basis of Shiga Toxin Neutralization by Human Antibodies Targeting Canonical Receptor‐Binding and Non‐Canonical Assembly Sites

open access: yesAdvanced Science, EarlyView.
Cryo‐electron microscopy structures reveal two distinct neutralization mechanisms of fully human monoclonal antibodies targeting the Shiga toxin 1a B subunit. RDS059 occludes the Gb3 receptor‐binding site, whereas RDS045 engages a lateral quaternary epitope to disrupt holotoxin assembly.
Jianting Ke   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy